International Meeting of Hypoxia and Oxidative Stress Studies
Understanding of Hypoxia and Oxidative Stress in Cancer

SPEAKERS

International Speakers

Prof. Margreet Vissers

University of Otago, Christchruch, New Zealand

Debabrata Banerjee, PhD

The State University of New Jersey

Prof. Salem Chouaib, PhD

Gustave Roussy Cancer Institute, France

Prof. Kato Mitsuyasu, MD, PhD

Faculty of Medicine, University of Tsukuba, Japan

Prof. Osamu Ohneda, MD, PhD

Faculty of Medicine, University of Tsukuba, Japan

Other Speakers

Prof. dr. Mohamad Sadikin, DSc
(Dept. Biochemistry & Molecular Biology Faculty of Medicine Universitas Indonesia)

DR.rer. physiol. dr. Septelia Inawati Wanandi
(Dept. Biochemistry & Molecular Biology Faculty of Medicine Universitas Indonesia)

Prof. DR. dr. Sri Widia A. Jusman, MS
(Dept. Biochemistry & Molecular Biology Faculty of Medicine Universitas Indonesia)

Prof. DR. dr. Soehartati Gondhowiardjo, SpRad.Onk (K)
(Dept. Radiotherapy, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital)

Dr. dr. Andhika Rachman, SpPD.KHOM
(Dept. Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital)

Dr. dr. Hariyono Winarto, SpOG(K)
(Dept. Obstetry & Gynecology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital)

Background

Cancer is still one of major health problems and important causes of morbidities and mortalities. Mechanism of cancer treatments focused mainly to eliminate or to stop cancer cells proliferation by surgery, chemotherapy and radiation therapy. Although chemo and radiation therapies are meant to interfere the DNA synthesis, both can kill cells by oxidative stress. In early 1930’s Warbug noted that cancer tissues metabolism is an anaerobic type. It is only recently realized that in cancer treatment, oxidative stress must be optimized and anti oxidative capacities should be suppress at the lowest level.
We have reported that in order to survive, hypoxia and oxidative stress induce the enhancement of Hypoxia Inducible Factor-1 (HIF-1). In this meeting, we will discuss and explore the further possibilities to obtain beneficial information in treating cancer
 
Sincerely,
Committee of CHOSS-
Department of Biochemistry and
Molecular Biology FMUI

Get in touch